Humacyte Stock Forecast

Sell candidate since May 29, 2026 Gain 7.36%

The Humacyte, Inc. stock price fell by -8.32% on the last day (Friday, 5th Jun 2026) from $0.0589 to $0.0540. During the last trading day the stock fluctuated 355.45% from a day low at $0.0505 to a day high of $0.230. The price has fallen in 5 of the last 10 days and is down by -14.15% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 thousand shares and in total, 1 thousand shares were bought and sold for approximately $78.84 .

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0452 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -27.35% during the next 3 months and, with a 90% probability hold a price between $0.0329 and $0.0799 at the end of this 3-month period.

HUMAW Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 03, 2026, and so far it has risen 16.00%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Humacyte, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0593 and $0.0774. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Humacyte, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.0503 and $0.0466. With no support from accumulated volume below today's level the risk is increased, as a drop below the support at $0.0466 may give a huge drop in the stock price.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.180 between high and low, or 355.45%. For the last week the stock has had daily average volatility of 182.14%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HUMAW) For The Upcoming Trading Day Of Monday 8th

For the upcoming trading day on Monday, 8th we expect Humacyte, Inc. to open at $0.112, and during the day (based on 14 day Average True Range), to move between $0.0051 and $0.103, which gives a possible trading interval of +/-$0.0979 (+/-1 935.02%) up or down from last closing price. If Humacyte, Inc. takes out the full calculated possible swing range there will be an estimated 1 935.02% move between the lowest and the highest trading price during the day. ⚠️ Extreme Volatility Warning: The projected daily trading range exceeds 1000%, indicating exceptionally high volatility. This level of price movement suggests significant market uncertainty and elevated risk. Traders should exercise extreme caution, consider reduced position sizes, and implement strict risk management strategies when trading this security.

Since the stock is closer to the resistance from accumulated volume at $0.0550 (1.85%) than the support at $0.0503 (6.85%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Humacyte, Inc. stock A Buy?

Humacyte, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.864 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 8, 2026 - $0.112 ( 106.48%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk